Contact Us
Email Us: Customer Service
Phone (US): 703-778-3080
Fax: 703-778-3081
-
Pay Invoice
Follow Us!
Latest Blogs
- Immunoassays: A $27 Billion Market of Intrigue and Opportunity April 12, 2024
- IVD in Egypt: $440 Million Market Lead by Immunodiagnostic and Molecular Diagnostic Growth April 11, 2024
- Momentum in Multiplex Testing for IVD April 1, 2024
- Defining the Molecular Point of Care (mPOC) Market in 2024 March 14, 2024
- Cancer, Obesity, Diabetes, and Cardiovascular Disease Drive South Korea’s IVD Investment March 8, 2024
Sitemap
Your Data and Privacy
About Us
Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.
Visit Science and Medicine Group
Visit Science and Medicine Group
Pfizer Zirabev Approval Sign of Growth Market for Biosimilars, Challenges for Cancer Drug Brands
News of an approval of a biosimilar for a major Roche cancer drug is, we think, evidence that U.S. biosimilars are a growth market opportunity. At the same time, the approval is a growth limiter for booming cancer drug markets. Pfizer Inc confirmed Friday that the the FDA approved its biosimilar to Avastin. Pfizer’s Zirabev […]
New Product Trends at ASMS 2019
The 67th American Society for Mass Spectrometry (ASMS) Conference on Mass Spectrometry and Allied Topics, held recently in Atlanta, Georgia, is a major showcase for mass spectrometry system (MS) introductions. Below are some of the trends evident among the many system launches. Small is Big Agilent Technologies introduced the LC/MSD iQ single quadrupole MS, measuring 12 x 18.7 in (305 […]
Will New HIV Recommendations Boost Test Volume?
From our partner publication LabPulse.com: New recommendations released June 11 from the U.S. Preventive Services Task Force (USPSTF) continue to strongly advise HIV screening for adolescents and adults, and for the first time they support preventive treatment for those at high risk. The guidance could boost volume for blood tests. Kalorama Information’s Infectious Disease World […]
Liquid Biopsy in 2019: Competitive and Growing
Liquid biopsies are a set of minimally invasive diagnostic methods that analyze tumor-derived materials that can be found circulating in biological fluids, to provide information for the diagnosis, treatment, and monitoring of cancer. While tissue biopsies and imaging techniques remain the current standards of care in the diagnosis of solid tumors, they have risks and […]
Cancer Therapeutics: The Targeting Advantage
The development of molecularly targeted cancer drugs is one of the most exciting advancements in oncology. The potential benefits from the identification of drug targets and the associated drugs and tests are illustrated by several novel examples, such as HER2/neu & Herceptin and Gleevec. The rising incidence of cancer, particularly in the over 50 population, […]
Are You Missing Out? 5 Exclusives and Scoops From Instrument Business Outlook
If you need to track instrument markets, and haven’t yet subscribed to Kalorama’s partner publisher Instrument Business Outlook (IBO), https://instrumentbusinessoutlook.com/product/instrument-business-outlook/ you could be missing out. Subscribers to IBO not only get the latest news, events and analysis in the analytical instrument industry delivered to their Inbox twice monthly, but they also receive the added benefit of IBO […]
Keep Up with CLIA Laboratory News and IVD Developments Daily with LabPulse.com
Kalorama Information’s publishing partner LabPulse.com recently started to present the voice of the laboratorian and present CLIA lab-related news. Using Kalorama Information’s data sources and an editorial team dedicated to breaking news, the website provides a unique perspective on CLIA lab and IVD product developments. The site provides a forum for pathologists, laboratorians, business managers, […]
Blood tau test works as biomarker for deadly Creutzfeldt-Jakob disease
By Emily Hayes, LabPulse.com editor in chief FROM Kalorama’s partner publication Lab Pulse.com Testing for the tau protein in blood could help predict the outlook for the rare and deadly Creutzfeldt-Jakob disease (CJD), a discovery that also has implications for research in Alzheimer’s disease and other neurodegenerative disorders, researchers reported in JAMA Neurology on May 6. Tau is […]
Extractables and Leachables in Single-Use Bioprocessing
Single-use or disposable biomanufacturing replaces stainless steel tanks, bioreactors, and plumbing with plastic, to provide flexibility, agility, and speed to the production of therapeutic proteins. A recent market study estimates demand for for Single Use Upstream Processing to grow at up to 15% per year through 2021, when demand will reach $3.7 billion.. As disposable processing worked […]
Yes, there are Issues With EMRs. But Paper Medical Records Are Not Coming Back Anytime Soon.
As detailed in a recent Linked In article (https://www.linkedin.com/pulse/yes-issues-emrs-paper-medical-records-coming-back-anytime-carlson/), articles that criticize the EHR tend to avoid a historical comparison to the days of paper-based records, and that’s partially because it’s hard to document those errors. EHRs in an odd way provide their own spotlight on their failures, whereas paper record errors would require extensive […]